InvestorsHub Logo
Followers 200
Posts 9988
Boards Moderated 0
Alias Born 06/14/2006

Re: sello post# 25389

Saturday, 02/17/2018 3:34:17 PM

Saturday, February 17, 2018 3:34:17 PM

Post# of 33254
They had the answer. They PR'd they had a $15 million dollar investor. They PR'd they were going to use the funds to pay for clinical's, pay off the debt and up-list. We got no further news on that until investors bugged them so much they released the share holder letter saying "We have decided not to take the financing because we didn't want to give up too much of the company at the the time" Well look at how much more they have given up because they didn't take the deal. Had they taken the deal maybe we'd be much further along and wouldn't have need the Eagle deal or the new options and warrants. Maybe we'd be trading at .50 instead of .05. If this was trading at .50 both Collier and Mann would be very rich men and the shareholders would be much better off than they are now. Instead they took a dilution deal that's keeping the share price down as well as making every share anyone purchases that much more less than it was the day before. I'd have to go back and look but I think when that deal was on the table the O/S was under 200 million.

At some point they are going to have to take a deal where they have to sell a portion of the company to get the financing needed to move to the next level. They can't keep diluting and raising the A/S, which we all know where that is going. R/S. Period.

STOP buying shares... period. The flippers can't flip and the note holders can't sell. Get the volume to 50K a day and send a clear message to management we're not taking it up the A$$ anymore. Let them find another way to finance the company. Period.

As far as the dilution as it is today. I have heard people suggest "why dilute now, why not wait until its at a higher price". Endonovo has no choice on when Eagle chooses to convert. Period.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENDV News